Privacy Regs Won't Prevent PBMs From Contacting Patients, Lawyer Suggests
Executive Summary
HHS' privacy regulations will allow PBMs to promote therapeutic switches to patients without prior patient authorization, provided the companies disclose to the patients how they were targeted, attorney David Bloch suggested during a marketing conference.